By Lindsay Brownell (BOSTON, MA and WESTON, FL) – Cantex Pharmaceuticals, Inc., a clinical-stage pharmaceutical company based in Weston, FL, and the Wyss Institute for Biologically Inspired Engineering at Harvard University announced today that Cantex has secured a global license from Harvard University’s Office of Technology Development (OTD) to develop azeliragon, a small-molecule drug in clinical…